KURA logo

Kura Oncology, Inc. (KURA) EBITDA

annual EBITDA:

-$192.35M-$27.39M(-16.61%)
December 31, 2024

Summary

  • As of today (September 12, 2025), KURA annual EBITDA is -$192.35 million, with the most recent change of -$27.39 million (-16.61%) on December 31, 2024.
  • During the last 3 years, KURA annual EBITDA has fallen by -$61.65 million (-47.17%).
  • KURA annual EBITDA is now -4790.97% below its all-time high of -$3.93 million, reached on December 31, 2014.

Performance

KURA EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKURAincome statement metrics

quarterly EBITDA:

-$65.51M-$8.93M(-15.78%)
June 30, 2025

Summary

  • As of today (September 12, 2025), KURA quarterly EBITDA is -$65.51 million, with the most recent change of -$8.93 million (-15.78%) on June 30, 2025.
  • Over the past year, KURA quarterly EBITDA has dropped by -$15.28 million (-30.42%).
  • KURA quarterly EBITDA is now -1393.89% below its all-time high of -$4.38 million, reached on March 31, 2015.

Performance

KURA quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKURAincome statement metrics

TTM EBITDA:

-$192.46M-$15.28M(-8.62%)
June 30, 2025

Summary

  • As of today (September 12, 2025), KURA TTM EBITDA is -$192.46 million, with the most recent change of -$15.28 million (-8.62%) on June 30, 2025.
  • Over the past year, KURA TTM EBITDA has dropped by -$13.18 million (-7.35%).
  • KURA TTM EBITDA is now -4289.12% below its all-time high of -$4.38 million, reached on March 31, 2015.

Performance

KURA TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKURAincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

KURA EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-16.6%-30.4%-7.3%
3 y3 years-47.2%-89.4%-45.1%
5 y5 years-185.1%-222.2%-162.3%

KURA EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-47.2%at low-294.8%at low-45.1%+1.3%
5 y5-year-185.1%at low-294.8%at low-162.3%+1.3%
alltimeall time-4791.0%at low-1393.9%at low-4289.1%+1.3%

KURA EBITDA History

DateAnnualQuarterlyTTM
Jun 2025
-
-$65.51M(+15.8%)
-$192.46M(+8.6%)
Mar 2025
-
-$56.58M(+241.0%)
-$177.19M(+4.5%)
Dec 2024
-$192.35M(+16.6%)
-$16.59M(-69.2%)
-$169.50M(-13.1%)
Sep 2024
-
-$53.78M(+7.1%)
-$195.08M(+8.8%)
Jun 2024
-
-$50.23M(+2.7%)
-$179.28M(+8.2%)
Mar 2024
-
-$48.89M(+15.9%)
-$165.63M(+10.2%)
Dec 2023
-$164.96M(+18.6%)
-$42.18M(+11.0%)
-$150.23M(+6.7%)
Sep 2023
-
-$37.98M(+3.8%)
-$140.73M(+1.9%)
Jun 2023
-
-$36.57M(+9.2%)
-$138.06M(+1.5%)
Mar 2023
-
-$33.50M(+2.5%)
-$136.07M(+0.9%)
Dec 2022
-$139.11M(+6.4%)
-$32.68M(-7.5%)
-$134.85M(+0.1%)
Sep 2022
-
-$35.31M(+2.1%)
-$134.75M(+1.6%)
Jun 2022
-
-$34.59M(+7.2%)
-$132.65M(+1.0%)
Mar 2022
-
-$32.28M(-0.9%)
-$131.29M(+1.4%)
Dec 2021
-$130.70M(+42.5%)
-$32.58M(-1.9%)
-$129.49M(+5.4%)
Sep 2021
-
-$33.21M(-0.1%)
-$122.82M(+8.5%)
Jun 2021
-
-$33.23M(+9.0%)
-$113.17M(+12.9%)
Mar 2021
-
-$30.48M(+17.6%)
-$100.27M(+12.8%)
Dec 2020
-$91.70M
-$25.91M(+10.0%)
-$88.85M(+10.1%)
Sep 2020
-
-$23.55M(+15.8%)
-$80.67M(+10.0%)
Jun 2020
-
-$20.33M(+6.6%)
-$73.37M(+8.2%)
DateAnnualQuarterlyTTM
Mar 2020
-
-$19.07M(+7.6%)
-$67.83M(+8.4%)
Dec 2019
-$67.48M(+7.3%)
-$17.72M(+9.1%)
-$62.56M(+3.0%)
Sep 2019
-
-$16.25M(+9.8%)
-$60.74M(+2.5%)
Jun 2019
-
-$14.79M(+7.2%)
-$59.25M(+0.6%)
Mar 2019
-
-$13.79M(-13.3%)
-$58.92M(-0.9%)
Dec 2018
-$62.87M(+74.4%)
-$15.90M(+7.8%)
-$59.47M(+10.0%)
Sep 2018
-
-$14.75M(+2.0%)
-$54.05M(+11.7%)
Jun 2018
-
-$14.47M(+0.9%)
-$48.40M(+16.5%)
Mar 2018
-
-$14.34M(+36.7%)
-$41.53M(+20.3%)
Dec 2017
-$36.05M(+27.2%)
-$10.49M(+15.3%)
-$34.52M(+10.7%)
Sep 2017
-
-$9.10M(+19.7%)
-$31.17M(+8.3%)
Jun 2017
-
-$7.60M(+3.8%)
-$28.79M(+4.1%)
Mar 2017
-
-$7.32M(+2.5%)
-$27.66M(+2.6%)
Dec 2016
-$28.34M(+20.2%)
-$7.14M(+6.3%)
-$26.95M(+2.6%)
Sep 2016
-
-$6.72M(+4.0%)
-$26.27M(+1.2%)
Jun 2016
-
-$6.46M(-2.3%)
-$25.97M(+3.5%)
Mar 2016
-
-$6.62M(+2.3%)
-$25.09M(+9.8%)
Dec 2015
-$23.58M(+499.5%)
-$6.47M(+0.7%)
-$22.86M(+39.5%)
Sep 2015
-
-$6.42M(+15.0%)
-$16.39M(+64.4%)
Jun 2015
-
-$5.58M(+27.3%)
-$9.97M(+127.3%)
Mar 2015
-
-$4.38M
-$4.38M
Dec 2014
-$3.93M
-
-

FAQ

  • What is Kura Oncology, Inc. annual EBITDA?
  • What is the all time high annual EBITDA for Kura Oncology, Inc.?
  • What is Kura Oncology, Inc. annual EBITDA year-on-year change?
  • What is Kura Oncology, Inc. quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Kura Oncology, Inc.?
  • What is Kura Oncology, Inc. quarterly EBITDA year-on-year change?
  • What is Kura Oncology, Inc. TTM EBITDA?
  • What is the all time high TTM EBITDA for Kura Oncology, Inc.?
  • What is Kura Oncology, Inc. TTM EBITDA year-on-year change?

What is Kura Oncology, Inc. annual EBITDA?

The current annual EBITDA of KURA is -$192.35M

What is the all time high annual EBITDA for Kura Oncology, Inc.?

Kura Oncology, Inc. all-time high annual EBITDA is -$3.93M

What is Kura Oncology, Inc. annual EBITDA year-on-year change?

Over the past year, KURA annual EBITDA has changed by -$27.39M (-16.61%)

What is Kura Oncology, Inc. quarterly EBITDA?

The current quarterly EBITDA of KURA is -$65.51M

What is the all time high quarterly EBITDA for Kura Oncology, Inc.?

Kura Oncology, Inc. all-time high quarterly EBITDA is -$4.38M

What is Kura Oncology, Inc. quarterly EBITDA year-on-year change?

Over the past year, KURA quarterly EBITDA has changed by -$15.28M (-30.42%)

What is Kura Oncology, Inc. TTM EBITDA?

The current TTM EBITDA of KURA is -$192.46M

What is the all time high TTM EBITDA for Kura Oncology, Inc.?

Kura Oncology, Inc. all-time high TTM EBITDA is -$4.38M

What is Kura Oncology, Inc. TTM EBITDA year-on-year change?

Over the past year, KURA TTM EBITDA has changed by -$13.18M (-7.35%)
On this page